Funder
Eshelman Institute for Innovation, University of North Carolina at Chapel Hill
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Reference178 articles.
1. Yang, Y. (2015). Cancer immunotherapy: harnessing the immune system to battle cancer, 125, 3335–3337.
2. Koulouris, A., & Tsagkaris, C. (2021). Real impact of novel immunotherapy drugs in cancer. The Experience of 10 Last Years. 1–24.
3. Megino-luque, C., Moiola, C. P. , Molins-escuder, C., Carlos, L., Gil-moreno, A., Matias-guiu, X., Colas, E., & Eritja, N. (2020). Small-Molecule Inhibitors as an Effective Therapeutic Strategy for Endometrial Cancer. Cancers (Basel), 12.
4. Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020). Recent advances in the development of protein – protein interactions modulators: mechanisms and clinical trials. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-020-00315-3
5. U.S.C.S.W Group. (2020). U.S. Cancer Statistics Data Visualizations Tool, based on 2019 submission data (1999-2017). U.S. Department Health Human Service Centers Disease Control Prevention National Cancer Institute. (available at https://www.cdc.gov/cancer/dataviz)
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献